Summary Report of the First International Workshop on PET/MR Imaging, March 19–23, 2012, Tübingen, Germany

We report from the First International Workshop on positron emission tomography/magnetic resonance imaging (PET/MRI) that was organized by the University of Tübingen in March 2012. Approximately 100 imaging experts in MRI, PET and PET/computed tomography (CT), among them early adopters of pre-clinical and clinical PET/MRI technology, gathered from March 19 to 24, 2012 in Tübingen, Germany. The objective of the workshop was to provide a forum for sharing first-hand methodological and clinical know-how and to assess the potential of combined PET/MRI in various applications from pre-clinical research to scientific as well as clinical applications in humans. The workshop was comprised of pro-active sessions including tutorials, specific discussion panels and grand rounds. Pre-selected experts moderated the sessions, and feedback from the subsequent discussions is presented here to a greater readership. Naturally, the summaries provided herein are subjective descriptions of the hopes and challenges of PET/MR imaging as seen by the workshop attendees at a very early point in time of adopting PET/MRI technology and, as such, represent only a snapshot of current approaches.

[1]  S. Cherry,et al.  Simultaneous PET and MR imaging , 1997, Physics in medicine and biology.

[2]  M. Schwaiger,et al.  Performance test of a LSO-APD PET module in a 9.4 Tesla magnet , 1997, 1997 IEEE Nuclear Science Symposium Conference Record.

[3]  K. Herholz,et al.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.

[4]  S. Cherry,et al.  A study of artefacts in simultaneous PET and MR imaging using a prototype MR compatible PET scanner. , 1999, Physics in medicine and biology.

[5]  Paul K Marsden,et al.  Simultaneous PET and NMR. , 2002, The British journal of radiology.

[6]  B. Hasegawa,et al.  Radiation dose estimate in small animal SPECT and PET. , 2004, Medical physics.

[7]  J. Boone,et al.  Small-animal X-ray dose from micro-CT. , 2004, Molecular imaging.

[8]  H. Groen,et al.  Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  E. Eisenhauer,et al.  RECIST revisited: a review of validation studies on tumour assessment. , 2006, European journal of cancer.

[10]  Michael O Zenge,et al.  High‐resolution continuously acquired peripheral MR angiography featuring partial parallel imaging GRAPPA , 2006, Magnetic resonance in medicine.

[11]  G. Johnson,et al.  In vivo small-animal imaging using micro-CT and digital subtraction angiography , 2008, Physics in medicine and biology.

[12]  Yong Li,et al.  The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy , 2008, Physics in medicine and biology.

[13]  B. Schölkopf,et al.  Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  R. Wahl,et al.  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.

[15]  R. Boellaard Standards for PET Image Acquisition and Quantitative Data Analysis , 2009, Journal of Nuclear Medicine.

[16]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[17]  B. Pichler,et al.  Pre-clinical PET/MR: technological advances and new perspectives in biomedical research , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Nassir Navab,et al.  Tissue Classification as a Potential Approach for Attenuation Correction in Whole-Body PET/MRI: Evaluation with PET/CT Data , 2009, Journal of Nuclear Medicine.

[19]  Heinz-Peter Schlemmer,et al.  PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications , 2010, Journal of Nuclear Medicine.

[20]  R. Günther,et al.  Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  Gaspar Delso,et al.  The effect of limited MR field of view in MR/PET attenuation correction. , 2010, Medical physics.

[22]  R. Boellaard Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments , 2011, The Journal of Nuclear Medicine.

[23]  G. Delso,et al.  Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.

[24]  T. Beyer,et al.  Variations in Clinical PET/CT Operations: Results of an International Survey of Active PET/CT Users , 2011, The Journal of Nuclear Medicine.

[25]  T. Beyer,et al.  The future of hybrid imaging—part 3: PET/MR, small-animal imaging and beyond , 2011, Insights into imaging.

[26]  M. Defrise,et al.  Time-of-flight PET data determine the attenuation sinogram up to a constant , 2012, Physics in medicine and biology.